David A. Siegel Organogenesis Holdings Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 489,000 shares of ORGO stock, worth $2.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

489,000

Previous 547,400 10.67%

Holding current value

$2.39 Million

Previous $1.57 Million 0.06%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.77 - $4.43 $161,768 - $258,711	-58,400 Reduced 10.67%	489,000 $1.56 Million
Q3 2024 Nov 14, 2024	SELL	$2.42 - $3.24 $167,464 - $224,208	-69,200 Reduced 11.22%	547,400 $1.57 Million
Q2 2024 Aug 14, 2024	SELL	$2.28 - $3.03 $450,983 - $599,334	-197,800 Reduced 24.29%	616,600 $1.73 Million
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $165,735 - $285,115	-63,500 Reduced 7.23%	814,400 $2.31 Million
Q4 2023 Feb 14, 2024	SELL	$1.97 - $4.21 $205,471 - $439,103	-104,300 Reduced 10.62%	877,900 $3.59 Million
Q3 2023 Nov 14, 2023	SELL	$2.34 - $4.43 $148,122 - $280,419	-63,300 Reduced 6.05%	982,200 $3.12 Million
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $75,050 - $169,850	-39,500 Reduced 3.64%	1,045,500 $3.47 Million
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $419,769 - $650,753	222,100 Added 25.74%	1,085,000 $2.31 Million
Q4 2022 Feb 14, 2023	SELL	$2.48 - $3.43 $1.04 Million - $1.44 Million	-420,800 Reduced 32.78%	862,900 $2.32 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $1.14 Million - $2.33 Million	361,800 Added 39.25%	1,283,700 $4.16 Million
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $343,650 - $590,875	72,500 Added 8.54%	921,900 $4.5 Million
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $940,738 - $1.39 Million	-145,400 Reduced 14.62%	849,400 $6.47 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $602,536 - $901,800	66,800 Added 7.2%	994,800 $9.19 Million
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $2.86 Million - $3.59 Million	208,800 Added 29.03%	928,000 $13.2 Million
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $6.06 Million - $9.44 Million	406,200 Added 129.78%	719,200 $12 Million
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $1.86 Million - $5.36 Million	254,300 Added 433.22%	313,000 $5.7 Million
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $213,081 - $442,011	58,700 New	58,700 $442,000
Q3 2020 Nov 16, 2020	SELL	$3.29 - $4.58 $174,041 - $242,282	-52,900 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.86 - $4.61 $10,010 - $16,135	-3,500 Reduced 6.21%	52,900 $203,000
Q1 2020 May 15, 2020	BUY	$2.92 - $5.31 $68,620 - $124,784	23,500 Added 71.43%	56,400 $182,000
Q4 2019 Feb 14, 2020	BUY	$4.7 - $8.11 $154,630 - $266,819	32,900 New	32,900 $158,000

Others Institutions Holding ORGO

# of Institutions

124

Shares Held

62M

Call Options Held

4.3K

Put Options Held

3.9K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $639M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account